Mark Jeffrey DeLong - 13 Jan 2025 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Signature
/s/ David Watson, attorney-in-fact for Mark DeLong
Issuer symbol
APLS
Transactions as of
13 Jan 2025
Net transactions value
-$45,895
Form type
4
Filing time
14 Jan 2025, 16:10:42 UTC
Previous filing
13 Aug 2024
Next filing
21 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $45,895 -1,599 -2.6% $28.70 58,796 13 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 10, 2025.